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ABSTRACT
The UvrA2 dimer finds lesions in DNA and initiates
nucleotide excision repair. Each UvrA monomer con-
tains two essential ATPase sites: proximal (P) and
distal (D). The manner whereby their activities enable
UvrA2 damage sensing and response remains to be
clarified. We report three key findings from the first
pre-steady state kinetic analysis of each site. Absent
DNA, a P2ATP-D2ADP species accumulates when the
low-affinity proximal sites bind ATP and enable rapid
ATP hydrolysis and phosphate release by the high-
affinity distal sites, and ADP release limits catalytic
turnover. Native DNA stimulates ATP hydrolysis by all
four sites, causing UvrA2 to transition through a dif-
ferent species, P2ADP-D2ADP. Lesion-containing DNA
changes the mechanism again, suppressing ATP hy-
drolysis by the proximal sites while distal sites cy-
cle through hydrolysis and ADP release, to populate
proximal ATP-bound species, P2ATP-Dempty and P2ATP-
D2ATP. Thus, damaged and native DNA trigger distinct
ATPase site activities, which could explain why UvrA2
forms stable complexes with UvrB on damaged DNA
compared with weaker, more dynamic complexes on
native DNA. Such specific coupling between the DNA
substrate and the ATPase mechanism of each site
provides new insights into how UvrA2 utilizes ATP
for lesion search, recognition and repair.
INTRODUCTION
Nucleotide excision repair (NER) processes diverse le-
sions in DNA damaged by chemical modification (e.g.
benzo[a]pyrene adducts) or UV radiation (e.g. cyclobutane
pyrimidine dimers) (1–4). This multi-step pathway employs
different proteins to scan the genome, distinguish dam-
aged from undamaged (native) DNA, incise and remove the
lesion-containing section of single-stranded DNA and, fi-
nally, mediate DNA synthesis using the undamaged strand
as template (Figure 1A). Given the importance of NER
for maintaining genome integrity, it is not surprising that
these protein functions have been conserved through evo-
lution, although, interestingly, the proteins themselves have
not. Defects in eukaryotic NER are associated with cancer
predisposition, UV sensitivity and premature aging among
other conditions related to genome instability.
In bacteria, NER is initiated by UvrA2, which scans ds-
DNA and binds to lesions with high affinity (5–8) (Fig-
ure 1A). Once a lesion is located, the DNA is handed off
to UvrB, a helicase that translocates along single-stranded
DNA and verifies the damage via contact with a -hairpin
(9–14). The timing and context of interaction between
UvrA2 and UvrB is still under investigation. Biochemical
and structural studies show that a UvrA2B2 complex can
form without DNA (15–17), and single molecule studies
implicate this complex in the initial search (6), but also in-
dicate that UvrA2 can find a lesion by itself and then re-
cruit UvrB (5). The handoff to UvrB is accompanied by ex-
pulsion of UvrA2 from the damage-sensing complex (18).
Lesion-bound UvrB recruits UvrC, a dual 5′ and 3′ nucle-
ase, to nick the damaged strand at sites flanking the lesion
(19–22). Subsequent strand displacement by UvrD helicase
allows gap filling by DNA polymerase I, and finally DNA
ligase completes repair (1).
During NER, UvrA2 binds DNA in a groove along
the dimer interface, and has been captured in broadly de-
fined ‘open’ and ‘closed’ conformations in crystal structures
(15,23–26). Figure 1B shows the structure of Geobacillus
stearothermophilus UvrA2 in an open conformation (26). It
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Figure 1. NER model and UvrA2 dimer showing two ATPase sites on each subunit. (A) Minimal NER pathway depicting lesion recognition by UvrA2,
verification by UvrB, nicking of damaged DNA by UvrC and removal by UvrD, followed by DNA resynthesis and ligation by polymerase and ligase. (B)
Geobacillus stearothermophilus UvrA2 structure with one subunit colored by domains and the other in gray. The composite proximal (pink circles) and
distal (green circles) ATPase sites made by ATP-binding domain I/signature domain II and ATP-binding domain II/signature domain I, respectively, are
labeled on the gray subunit, as are Walker A and B residues in each site. The bound ADP is depicted as sticks (yellow) and the DNA binding groove by
a dashed line (PDB code: 2R6F) (26). (C) Schematic of the composite ATPase sites, showing the two nucleotide-binding domains (NBD) in each subunit
(chains A, B).
has been proposed that transient switching between these
conformations enables UvrA2 to scan DNA for lesions (15).
UvrA2 is also an ATPase from the ATP-binding cassette
(ABC) family of proteins, which have a distinctive compos-
ite nucleotide-binding site for coupling ATP binding and
hydrolysis to conformational changes (Figure 1C) (27–31).
UvrA2 is an unusual member of this family in that it has two
ATPase sites per monomer instead of one, resulting in a to-
tal of four sites on the dimer (26,32). The two sites on each
monomer are termed ‘proximal’ and ‘distal’, and each site
comprises an ATP-binding domain with Walker A and B
motifs and a signature domain with the ABC signature mo-
tif. The proximal site, which lies closer to the DNA-binding
groove at the dimer interface, is formed by ATP-binding do-
main I and signature domain II (which also has residues
critical for interaction with DNA and with UvrB) (15). The
distal site is formed by ATP-binding domain II and signa-
ture domain I (which has the UvrB-binding domain and
DNA-binding insertion domain) (Figure 1B and C).
Previous research on how UvrA2 utilizes ATP has shown
that both proximal and distal ATPase sites are required for
its function (25,32–34). Mutants of conserved Walker A and
B motif residues have been employed to parse the role of
each ATPase site; specifically, a Walker A lysine that hydro-
gen bonds with the -phosphate and is important for nu-
cleotide binding, and a Walker B glutamate that serves as a
general base to activate water for ATP hydrolysis (31,35,36).
Some key findings from these studies are: UvrA2 dimer is
more stable in the presence of ATP (37,38), possibly as a
mixed nucleotide-bound/free species in which the proximal
site is empty and the distal site may be occupied by ATP
or ADP (5,33,39); ATP promotes UvrA2 interaction with
UvrB and its recruitment to the damage site, again possi-
bly as a mixed species in which the distal site is ATP-bound
(5,33,40); and, ATP hydrolysis facilitates UvrA2 dissocia-
tion from DNA (34). Based on structural, biochemical and
in vivo single-molecule imaging data, it has been proposed
that the proximal site is involved in regulating interactions
among UvrA2, UvrB and DNA, and the distal site is in-
volved in genome scanning (5,15). However, some studies
have yielded discordant results; for example, the ATPase
site mutants have been reported to suffer complete loss of
ATP binding and hydrolysis or to maintain residual activity,
which confounds interpretation of their function, and have
been found either proficient or deficient in specific bind-
ing to lesions (5,32–34). These discrepancies, which could
be due to differences in assays, reaction conditions and/or
nucleotide or ATPase contaminants in the protein prepa-
rations, have hindered definitive understanding of the role
of UvrA2 ATPase activity in NER. More importantly, the
stoichiometry and kinetics of ATP binding and hydroly-
sis catalyzed by UvrA2 have not been determined thus far.
Due to this fundamental gap in knowledge, questions about
the proximal and distal site ATPase mechanisms, especially
how they are coupled to each other and to UvrA2 interac-
tions with DNA and UvrB, remain to be resolved.
In this study, we measured the rates of distinct steps in
the ATPase reaction catalyzed by each site on UvrA2, from
ATP binding to hydrolysis and product release, in the ab-
sence and presence of native and lesion-containing DNA.
We chose G. stearothermophilus UvrA2 as the model pro-
tein, since crystal structures of this protein in different states
are available to help interpret the kinetic data (15,26,41,42).
We also leveraged information from the highest resolution
UvrA2 structure (2.0 Å), reported here for the first time
(Thermotoga maritima UvrA2; PDB code: 6N9L). Before
initiating mechanistic analysis, we addressed the problem of
potential nucleotide contamination by testing G. stearother-
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mophilus UvrA2 purified by a previously reported proto-
col (26). The results of a luciferase-based assay for ADP
and ATP showed that the protein co-purifies with about
one ADP bound per UvrA2. Adjustment of the purifica-
tion protocol includes mild heat treatment that successfully
removed all the ADP (Supplementary Figure S1). We also
prepared a double Walker A mutant with the conserved
lysines in both sites (K37 and K643) mutated to alanine,
in order to detect any contaminating ATPases against a
background of catalytically inactive UvrA2. ATPase assays
with K37A-K643AUvrA2 found no detectable activity (Figure
6A). Pre-steady state kinetic analysis of wild-type and mu-
tant UvrA2 proteins identified stark asymmetry in the ATP
binding and hydrolysis activities of the proximal and dis-
tal sites, and showed that they are modulated differentially
by native and lesion-containing DNA. The findings offer
new ideas for understanding how UvrA2 utilizes ATP to dis-
criminate between native versus damaged DNA and initiate
NER.
MATERIALS AND METHODS
Proteins, DNA and other reagents
Wild-type G. stearothermophilus UvrA2 was overexpressed
in Escherichia coli Rosetta (DE3) pLysS cells (Millipore
Sigma) from pET28a-NHis-UvrA plasmid and purified by
a modified version of a previously described procedure (15).
Briefly, cells were grown from a fresh colony in LB media
at 37◦C to 0.6 OD600, induced with 1 mM isopropyl -D-
1-thiogalactopyranoside (IPTG) for 3 h at 30◦C and pel-
leted by centrifugation (all steps after growth were at 4◦C
unless noted otherwise). The cell pellet was resuspended
and lysed by homogenization in buffer (50 mM Tris–HCl,
pH 8, 0.5 M NaCl, 20% sucrose) containing a protease
inhibitor cocktail and 1 mM phenylmethylsulfonyl fluo-
ride (PMSF) (Millipore Sigma). To remove DNA and nu-
cleotide contaminants, the lysate was warmed at 55◦C for
15 min and then cooled to 4◦C, clarified by ultracentrifu-
gation (50 000 g), brought to 1 M NaCl and treated with
0.5% polyethyleneimine (PEI), and then clarified again by
centrifugation (25 000 g). Next, protein was precipitated
overnight with 65% ammonium sulfate (43) and the pel-
let was suspended in buffer (50 mM Tris–HCl, pH 8, 0.5
M NaCl, 10 mM imidazole, 5 mM -mercaptoethanol) for
column chromatography. The protein solution was puri-
fied over a Ni-NTA agarose column (Qiagen) using a 10–
150 mM imidazole gradient in the same buffer. Peak frac-
tions were pooled, diluted with buffer (50 mM Tris–HCl,
pH 7.4, 5 mM -mercaptoethanol) to 0.2 M NaCl and
further purified on a Heparin Sepharose 6 column (GE
Healthcare) using a 0.2–1 M NaCl gradient in the same
buffer. Finally, peak fractions were pooled, the protein was
dialyzed against buffer (25 mM Tris–HCl, pH 7.4, 0.25
M NaCl, 20% glycerol, 1 mM DTT), and aliquots were
flash frozen in liquid nitrogen for storage at −80◦C (freshly
thawed aliquots were used for each experiment). Prepa-
ration of overexpression clones for UvrA2 Walker A mu-
tants, K37AUvrA2, K643AUvrA2 and K37A-K643AUvrA2, has
been described previously (15), and clones for Walker B mu-
tants, E512AUvrA2 and E854AUvrA2, were prepared using the
QuikChange Lightning kit (Agilent Technologies); primer
sequences: E512A forward: 5′-CGT GCT CGA CGC GCC
GTC GAT CGG-3′; E512A reverse: 5′-CCG ATC GAC
GGC GCG TCG AGC ACG-3′; E854A forward: 5′-GCT
CTA CAT TTT GGA CGC GCC GAC GAC C-3′; E854A
reverse: 5′-GGT CGT CGG CGC GTC CAA AAT GTA
GAG C-3′. All mutant proteins were purified as described
for wild-type UvrA2 above. Protein samples were run on an
agarose gel and stained with ethidium bromide to test for
DNA contamination (none detected) and by a luciferase-
based bioluminescence kit (Millipore Sigma) for nucleotide
contamination (no significant level of ADP or ATP was de-
tected in proteins purified by the above protocol; see Sup-
plementary Data for method and results, Figure S1). E. coli
phosphate binding protein (PBP) was purified and labeled
with MDCC as described (44). Preparation and crystalliza-
tion of T. maritima UvrA 117-399 is described in Supple-
mentary Data.
All DNAs were purchased from Integrated DNA Tech-
nologies. Unlabeled DNA strands were purified in-house
by electrophoresis in 6 M urea/18% (w/v) polyacrylamide
gels followed by electroelution and ethanol precipitation,
and fluorescein-labeled strands were obtained HPLC pu-
rified and desalted. The sequences are: template: 5′-TGG
ATT ACT TAC GGC CAC ATT ACT ACT GGA ACT
CAG AAC GAG CTG ACA GG-3′ (unlabeled for ATPase
assays with native DNA and 5′ end-labeled with 6-FAM for
native DNA binding assays); native complement: 5′-CCT
GTC AGC TCG TTC TGA GTT CCA GTA GTA ATG
TGG CCG TAA GTA ATC CA-3′; fluorescein lesion com-
plement: 5′-CCT GTC AGC TCG TTC TGA GTT CCA
G/iFluorT/A GTA ATG TGG CCG TAA GTA ATC CA-
3′. Duplex DNA substrates were prepared by annealing
complementary strands in 1:1 ratio by heating for 1 min at
95◦C followed by slow cooling O/N to room temperature in
buffer (20 mM Tris–HCl, pH 7.4, 0.1 M NaCl), and tested
by non-denaturing PAGE to confirm >95% duplex. DNA
binding to UvrA2 was measured by change in fluorescence
anisotropy of fluorescein end-labeled (undamaged) or inter-
nally labeled (damaged) DNAs (see Supplementary Data
for method and results, Figure S6). All nucleotides, ATP,
ADP, mant-ATP and mant-ADP, were purchased from Mil-
lipore Sigma.
Mant-nucleotide binding assays
Mant-ATP and mant-ADP binding kinetics were measured
by monitoring change in fluorescence of the mant fluo-
rophore (λEX = 352 nm, λEM > 420 nm) over time when in-
creasing concentrations of the nucleotide were mixed with
wild-type or mutant UvrA2 in the absence or presence of
DNA in a stopped-flow instrument (KinTek Corp, Austin
TX) in buffer (20 mM Tris–HCl, pH 7.4, 0.15 M NaCl, 5%
glycerol, 5 mM MgCl2, 5 mM DTT) at 40◦C (final con-
centrations: 0.1 M UvrA2, ± 0.2 M DNA and 2.5–10
M mant-ATP or mant-ADP). Mant-ADP dissociation ki-
netics were measured directly by monitoring the change
in fluorescence over time on mixing wild-type or mutant
UvrA2 pre-incubated with mant-ADP, in the absence or
presence of DNA, with excess unlabeled ADP or ATP
on the stopped-flow (final concentrations: 0.1 M UvrA2,
± 0.2 M DNA, 10 M mant-ADP and 2 mM ADP or
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2 mM ATP). The signal from 3 to 5 traces was averaged
for each experiment and corrected for background fluo-
rescence from mant-nucleotide alone (mant-ADP photo-
bleaching caused a slow, linear decrease in signal to 15%
at most over the 150-s dissociation time scale). Associa-
tion data were fit to a single exponential equation to deter-
mine the observed rate (kobs), and linear dependence of this
rate versus nucleotide concentration yielded the bimolecu-
lar rate constant, kon and the dissociation rate, koff (kobs =
kon[mant-nucleotide] + koff). Error bars report standard er-
ror of the mean (S.E.M.) from N = 3. Dissociation data were
fit to a single exponential equation to determine koff.
The stoichiometry of nucleotide binding was measured
by Förster resonance energy transfer (FRET) between
UvrA2 tryptophans (donor) and mant-ADP (acceptor).
UvrA2 (3 M) was titrated with mant-ADP (0–20 M)
in buffer (20 mM Tris–HCl, pH 7.4, 0.15 M NaCl, 5%
glycerol, 5 mM MgCl2, 5 mM DTT) at 40◦C, and fluores-
cence intensity was measured after mixing and a 1-min in-
cubation (λEX = 290 nm, λEM = 305–400 nm; Jobin-Yvon
Horiba Fluoromax-3). Emission spectra were collected for
UvrA2 alone (D), mant-ADP alone (A) and UvrA2 plus
mant-ADP (DA), and the spectra were integrated using
Grams/AI software (Thermo Scientific); the fluorescence
intensity of A was subtracted from that of DA to correct
for background mant-ADP excitation at 290 nm, and flu-
orescence intensity of D was aligned with the initial value
for DA (at zero mant-ADP). FRET efficiency was calcu-





; FDA and FD are the corrected
fluorescence intensities of DA and D, respectively. EFRET
values from three independent experiments were averaged
and plotted versus mant-ADP concentration. The inflec-
tion point between initial and final slopes of the isotherm
yielded the stoichiometry of mant-ADP binding to UvrA2
(error bars report S.E.M. from N = 3).
Phosphate release assays
Phosphate (Pi) release from UvrA2 after ATP hydrolysis
was measured under pre-steady state conditions by mon-
itoring change in fluorescence of the MDCC fluorophore
(λEX = 425 nm, λEM > 450 nm) when wild-type or mutant
UvrA2 and MDCCPBP, in the absence or presence of DNA,
were mixed with ATP on a stopped flow instrument in buffer
(20 mM Tris–HCl, pH 7.4, 0.15 M NaCl, 5% glycerol, 5 mM
MgCl2, 5 mM DTT) containing a Pi contaminant mopping
system of 0.1 unit/mL polynucleotide phosphorylase (Mil-
lipore Sigma) and 0.2 mM 7-methylguanosine (R.I. Chemi-
cal Inc., Orange, CA) at 40◦C (final concentrations: 0.125–2
M UvrA2 and 1 mM ATP, or 2 M UvrA2 and 10 M
to 2 mM ATP, or 0.25 M UvrA2, ± 1 M DNA and 1
mM ATP, and 15 M MDCCPBP) (45). The signal from 4 to
6 traces was averaged for each experiment, converted to Pi
concentration using a calibration curve generated with stan-
dard Pi solution (Millipore Sigma) under the same condi-
tions (Supplementary Figure S4A), and corrected for a low
background signal at zero time. The data were fit to a dou-
ble exponential + linear equation (A1e−k1t + A2e−k2t + k3t;
kinetic traces with lag, burst and linear phases; Supplemen-
tary Figure S4D) or linear equation (linear kinetic traces)
for initial estimation of the burst and steady state rates (kcat
= linear slope/4 sites × [UvrA2] for wild-type or slope/2
sites × [UvrA2] for mutants). Data from the concentration
series were fit simultaneously using KinTek and FitSpace
Explorer (46–48) to determine a minimal kinetic mecha-
nism. The raw data, together with details of model devel-
opment and data fitting by KinTek Explorer, are available
as Supplementary Data at NAR Online.
RESULTS
Transient kinetic measurements of wild-type UvrA2, as well
as proximal and distal Walker A and B mutants, were per-
formed to detail the ATP binding, hydrolysis and product
release mechanisms of these sites. The ATPase kinetics in
the absence and presence of DNA reveal specific coupling
between each site and type of DNA, which could help ex-
plain the different actions of UvrA2 on native DNA (search
for lesions) and at a damage lesion (signal repair).
Asymmetric nucleotide binding to proximal (weak) and distal
(tight) ATPase sites on the UvrA2 dimer
We used ATP and ADP analogs with the ribose modified by
2′(3′)-O-(N-methylanthraniloyl) fluorophore (mant) (49) to
measure the kinetics and stoichiometry of nucleotide bind-
ing to UvrA2. Mant-nucleotide fluorescence intensity in-
creases on binding to UvrA2, as reported previously for
other ATPases (50,51). Monitoring the signal over time af-
ter mixing 0.1 M UvrA2 with 10 M mant-ATP on a
stopped flow yields a binding rate of 0.6 s−1 (Figure 2A;
kinetic trace under pseudo first order conditions fit with a
single exponential function). A titration with mant-ATP re-
veals linear concentration dependence of the binding rate,
providing a bimolecular association rate constant from the
slope and a rough estimate of the dissociation rate from the
Y-intercept (kon = 0.4 × 105 M−1 s−1, koff(estimate) = 0.2 s−1;
Figure 2A inset; Supplementary Figures S2B, S2D, Table
1). A similar analysis of mant-ADP binding kinetics yields
comparable rates (kon = 1.3 × 105 M−1 s−1, koff(estimate) =
0.06 s−1; Figure 2B, Supplementary Figures S2C, S2E, Ta-
ble 1). The dissociation rate was also measured directly by
pre-incubating mant-ADP with UvrA2 and mixing with ex-
cess unlabeled ADP to prevent mant-ADP rebinding. In
this experiment, mant-ADP fluorescence decreases as a sin-
gle exponential over time and yields a slow koff = 0.03 s−1
(Figure 2C). The koff/kon ratio yields a dissociation constant
of 0.23 M for mant-ADP, indicating a high affinity and
stable interaction with UvrA2 (KD1; Table 1). Mant-ATP
dissociation was not measured directly, as this nucleotide is
hydrolyzed in the time frame of the experiment (from the
mant-ATP koff estimate above, KD1 ∼5 M).
The next step was to determine how many of the four AT-
Pase sites on UvrA2 bind nucleotides. We measured the sto-
ichiometry by titrating UvrA2 (3 M) at a concentration
well above the measured dissociation constant (0.23 M)
with increasing amounts of mant-ADP. In this case, the re-
porter was UvrA2 tryptophan fluorescence quenching due
to FRET to mant-ADP (52). Figure 2D shows distances
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Figure 2. Kinetics, affinity and stoichiometry of nucleotide binding to UvrA2. Nucleotide binding was monitored by increase in fluorescence on mixing
UvrA2 with (A) mant-ATP or (B) mant-ADP (final: 0.1 M UvrA2 and 2.5–10 M mant-nucleotide; 10 M trace shown here; see Supplementary Figure
S2). Time traces fit to a single exponential yield rates that depend linearly on nucleotide concentration, and the slope yields kon = 0.4 and 1.3 × 105 M−1
s−1 for mant-ATP and mant-ADP, respectively (A and B, inset). (C) Nucleotide dissociation was measured by pre-incubating mant-ADP with UvrA2 and
mixing with excess unlabeled ADP chase (final: 0.1 M UvrA2, 10 M mant-ADP and 2 mM ADP). The decrease in fluorescence fit to a single exponential
yields koff = 0.03 ± 0.0002 s−1 (koff/kon yields a tight KD1 = 0.23 M for mant-ADP; Table 1). (D) UvrA2 structure showing distances between tryptophans
W307, W609 (donor) and nucleotides (acceptor mant-ADP) (PDB code: 2R6F). (E) Nucleotide binding stoichiometry was measured by FRET on titrating
UvrA2 (3 M) with increasing mant-ADP; error bars report S.E.M. (N = 3). The inset shows spectra for UvrA2 alone (donor, D) and with mant-ADP
(donor + acceptor, D+A). The binding isotherm has an inflection point of 6.8 M (2.3 mant-ADP per UvrA2 dimer).
Table 1. Measured parameters for the UvrA2 ATPase mechanism
UvrA2 DNA
mantATP kon
(× 105 M−1 s−1)
mantADP kon






(ATP chase; s−1) kcat(s−1)
Wild Type None a0.4 1.3 0.03 0.2 2.3 b0.2
Native 0.6 1.6 0.04 0.3 8.7 0.8
Lesion 0.6 1.7 0.05 0.3 13 1.4
K37A None 0.5 2.3 0.05 0.2 0.06 0.04
Native 0.8 2.2 0.1 0.4 0.1 0.04
Lesion 0.7 2.2 0.1 0.5 0.1 0.03
E512A None 0.5 2.6 0.05 0.2 5 0.3
Native 0.6 2.6 0.1 0.4 15 0.6
Lesion 0.7 2 0.1 0.6 25 2
K643A None cND ND ND ND ND 0.1
Native ND ND ND ND ND 1.4
Lesion ND ND ND ND ND 0.3
E854A None 0.9 4 0.07 0.2 4 0.6
Native 1 3.3 0.1 0.4 7 0.3
Lesion 0.9 3.2 0.2 0.5 13 0.3
aS.E.M. range from 2 to 10% for all reported values from 2 to 4 independent measurements.
bkcat = linear slope/4 sites × [UvrA2] for wild-type, and slope/2 sites × [UvrA2] for mutants.
cND = not detectable.
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between potential tryptophan donors and mant-ADP ac-
ceptors at the proximal and distal sites in G. stearother-
mophilus UvrA2; tryptophan - mant R0 ∼25 Å (52,53). As
shown in Figure 2E, FRET efficiency increases linearly with
mant-ADP concentration until saturation, and the inflec-
tion point yields a ratio of 2.3 mant-ADP bound per UvrA2
(Figure 2E, inset shows the emission spectra of UvrA2,
alone and with mant-ADP). These results indicate asymme-
try in the nucleotide binding properties of UvrA2 since only
two of the four ATPase sites bind ADP with high affinity.
The above experiments do not reveal which two sites
bind ADP tightly and whether asymmetry exists within a
monomer (between each proximal and distal site) or be-
tween monomers (between the pairs of sites across the
dimer) (Figure 1B and C). We addressed this question us-
ing ATPase mutants in which the conserved Walker A lysine
was replaced with alanine to disrupt ATP binding (proxi-
mal: K37A; distal: K643A; Figure 3A) (54), and the con-
served Walker B glutamate was replaced with alanine to
disrupt ATP hydrolysis while (likely) retaining ATP bind-
ing (proximal: E512A; distal: E854A; Figure 3A) (36). The
kinetics of ATP and ADP binding to the mutants was mea-
sured as for wild-type UvrA2 (Figure 2A). As shown in Fig-
ure 3B and C, both Walker B mutants, E512AUvrA2 (prox-
imal) and E854AUvrA2 (distal), exhibit similar mant-ATP
and mant-ADP binding kinetics as wild-type (Figure 2A),
with kon on the order of 105 M−1 s−1. Thus, this mutation
does not disrupt nucleotide binding to UvrA2 (Supplemen-
tary Figures S2D, S2E and Table 1); a slightly higher signal
for mant-ATP-bound E854AUvrA2 may indicate a change
in the local environment of the nucleotide, although this
difference is not observed with mant-ADP. The Walker A
mutant K37AUvrA2, in which proximal ATP binding is dis-
rupted while the distal site is intact, also exhibits a simi-
lar nucleotide binding rate. In contrast, the complementary
Walker A mutant K643AUvrA2, in which distal ATP binding
is disrupted while the proximal site is intact, shows no bind-
ing at nucleotide concentrations tested on the stopped flow
(Figure 3B and C; Supplementary Figures S2D, S2E). Ac-
cording to these results, distal sites bind mant-nucleotides,
but proximal sites do not. Mant-ADP dissociation measure-
ments show that the three mutants, K37AUvrA2, E512AUvrA2
and E854AUvrA2, bind mant-ADP with comparable high
affinity and stability to wild-type (koff ∼0.05 s−1, KD ∼0.2
M; Figure 3D, Table 1), whereas K643AUvrA2 does not
show any change in the baseline signal, consistent with its
inability to bind mant-ADP under these conditions (Fig-
ure 3D). Moreover, the FRET-based assay used to mea-
sure mant-ADP binding stoichiometry (Figure 2E) reports
weak interaction at best for K643AUvrA2 (Supplementary
Figure S2F). Together, these results clearly indicate that dis-
tal sites on UvrA2 bind ATP and ADP tightly, whereas
proximal sites have weaker affinity. This finding is consis-
tent with the detection of [-32P]ATP bound to K37AUvrA2
but not K643AUvrA2 in a nitrocellulose filter binding assay
(15). Thus, we can conclude that nucleotide binding asym-
metry exists between the proximal and distal ATPase sites
on each monomer in UvrA2, and the stoichiometry of two
mant-ADP per UvrA2 reflects occupancy of the two high-
affinity distal sites on the dimer (Figure 1B and C).
Structural analysis of asymmetric nucleotide binding by
UvrA2
To gain additional insights into the finding that nucleotides
are held more tightly by the distal ATPase sites than prox-
imal sites, we interrogated atomic models of several UvrA2
orthologs for underlying sources of the differential affin-
ity. These included a newly determined high resolution 2.0
Å crystal structure of UvrA2 from T. maritima (Supple-
mentary Figure S3A, Supplementary Table S1; PDB code:
6N9L) as well as published structures of G. stearother-
mophilus, T. maritima, Deinococcus radiodurans and My-
cobacterium tuberculosis UvrA2 (15,23–26) (discussion of
Figure 3. The distal ATPase sites on UvrA2 bind nucleotides with high affinity. (A) Aligned proximal and distal ATPase sites depicting Walker A and
B residues (PDB code: 2R6F). Kinetics of (B) mant-ATP and (C) mant-ADP binding to Walker A (K37AUvrA2, K643AUvrA2) and B (E512AUvrA2,
E854AUvrA2) mutants of the proximal and distal sites were measured as described for wild-type UvrA2 in Figure 2 (final: 0.1 M UvrA2 and 2.5–10 M
mant-nucleotide; 10 M trace shown; Supplementary Figure S2). All mutants yielded binding rate constants similar to wild-type, except for K643AUvrA2,
which did not bind either nucleotide (Table 1). (D) mant-ADP dissociation was measured as for wild-type in Figure 2 (final: 0.1 M UvrA2, 10 M
mant-ADP and 2 mM ADP). All mutants had similar dissociation rates as wild-type, except for K643AUvrA2, which did not bind mant-ADP (Table 1).
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the new T. maritima UvrA2 structure is restricted to aspects
relevant to this kinetic study; the reader is referred to the
cited reports for detailed structural descriptions of UvrA2).
Our analysis examined the number and types of interac-
tions between the ATPase sites and the bound nucleotides,
which was simplified by the high degree of sequence and
structural conservation in both proximal and distal sites in
these orthologs. Indeed, the eight ATPase sites in question
could be easily superimposed using the Walker A sequence
(Supplementary Table S2), highlighting the overall similar-
ity in these domains among currently available structures.
The largest deviation in the superpositions was found in the
ABC signature and the Q-loop motifs.
Detailed examination of the complete set of contacts be-
tween UvrA2 and nucleotide at all the sites revealed 21 po-
lar and 28 hydrophobic contacts per site, on average (both
proximal and distal sites make 21 polar contacts, and 29
and 27 hydrophobic contacts, respectively). These contacts
are highly conserved between the two types of sites and be-
tween orthologs, with one notable exception. The proximal
site has a glutamine residue that precedes the ABC signature
motif by five residues (Q821, G. stearothermophilus residue
numbering; Figure 4A). In contrast, the distal ATPase site
of every UvrA2 ortholog features an arginine in the equiv-
alent position, which is involved in a pi–cation interaction
with the aromatic base of adenine (R480; Figure 4B). While
both residues stack on the adenine base, the more extensive
interaction and pi–cation stacking by R480 implicate this
residue in the higher affinity of distal sites for nucleotides.
Both R480 and Q821 are absolutely conserved in a large
primary sequence alignment of UvrA proteins (Figure 4 in-
sets), and are located at the end of a region previously noted
as the ‘structurally diverse region’ (SDR) in ABC importers
(55,56).
To determine if our findings about the potential roles of
the arginine and glutamine residues in UvrA generalize to
the larger ABC family of ATPases, we interrogated the Pro-
tein Data Bank using the ScanProsite (ExPASy) tool and
search patterns that include these residues in the SDR re-
gions of UvrA: R-X(4)-L-S-G(2)-X and Q-X(4)-L-S-G(2)-
X. The search revealed 13 entries containing both patterns,
all of which were ABC ATPases. Three of these entries cor-
responded to a heterodimeric ABC ATPase, the ABCE1
RNase L inhibitor (PDB codes: 3J16, 4CRM and 5LL6),
and the remaining 10 were other UvrA proteins. Separate
searches with one or the other pattern revealed that the
Energy-coupling factor ABC ATPase importer retained an
arginine in a similar position to R480 at one nucleotide
binding site and an alanine in a similar position to Q821
at the second site (PDB codes: 4HLU and 4ZIR) (57,58).
It would be interesting to determine whether this difference
confers asymmetry in nucleotide binding (and catalytic ac-
tivity, as shown below) to other dimeric ABC ATPases, as
observed with UvrA2.
Asymmetric and linked ATPase activities of the proximal
(slow) and distal (rapid burst) sites on UvrA2
The discovery of differential nucleotide binding by the
proximal and distal sites raised the question whether
these sites also hydrolyze ATP differentially. If true, this
Figure 4. UvrA structures showing interactions of ADP with R480 and
Q821 (G. stearothermophilus residue numbers). (A) Representation of the
T. maritima proximal ATPase site showing K37, E512 and ADP, as well as
Q821 highlighted in solid red among transparent Q821 residues from all
other proximal ADP-bound UvrA structures (PDB ID: 2R6F, 2VF7 and
2VF8). (B) T. maritima distal ATPase site showing K643, E854 and ADP
(ADP from 2R6F is also shown, demonstrating a ring flip observed in this
site in some UvrA structures). T. maritima R480 is highlighted in solid red
among transparent R480 residues from all other distal ADP-bound UvrA
structures (PDB ID: 2R6F, 3UX8, 2VF7 and 2VF8) (15,25,26). The insets
show sequence alignment of several UvrAs and ABC transporters. R480
and Q821 are highlighted in blue and the signature domain is shown in
maroon. UvrAs: Gst – G. stearothermophilus, Tma – T. maritima, Dra – D.
radiodurans, Hpy – H. pylori, Has – H. salinarum, Mtu – M. tuberculosis,
Cmi – C. michiganensis, Eco – E. coli, Ngo – N. gonorrhoeae, Tth – T. ther-
mophilus, Atu – A. tumefaciens; Transporters: Lb1/2 – (EcfA-A´) L. brevis
chain A and chain C, EcB – (BtuD) E. coli; DNA damage repair protein:
Pfu – (Rad50) P. furiosus.
possibility has profound implications for understanding
how UvrA2 utilizes the ATPase reaction to drive NER. We
addressed this question by analyzing UvrA2-catalyzed ATP
hydrolysis and phosphate (Pi) release under pre-steady
state conditions, which can reveal the stoichiometry of ATP
hydrolysis and rate-limiting steps in the mechanism. We
used an assay developed by the Webb group in which rapid
(108 M−1 s−1) and high affinity (KD = 0.1 M) binding
of Pi by phosphate-binding protein (PBP) labeled with
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7-diethylamino-3-((((2-maleimidyl)ethyl)amino)carbonyl)
coumarin (MDCC) leads to a large increase in MDCC flu-
orescence (44). Due to these properties, MDCCPBP reports
any free Pi in solution effectively at the rate at which it is
released upon ATP hydrolysis by UvrA2, thus enabling
transient kinetic measurements.
The reaction was initiated by mixing UvrA2 and
MDCCPBP with ATP in a stopped-flow apparatus and Pi
formation was monitored over time (Figure 5A). The ki-
netic trace for 2 M UvrA2 mixed with 1 mM ATP shows
a slight lag phase and then a burst of Pi followed by a lin-
ear phase. The lag indicates at least two steps in the reac-
tion leading to fast ATP hydrolysis and Pi release (which
can be described by a double exponential function), and
then a slow step limits steady state turnover (which can
be described by a linear function) (59). Fitting the trace
to a double exponential + linear function yields a rate of
2.4 s−1 for the burst, and the linear slope yields a kcat of
0.2 s−1 (slope/4 sites × [UvrA2]); the same kcat was ob-
tained from steady state malachite green-based ATPase ex-
periments (data not shown) (60). The burst amplitude is
3.4 M, which represents the amount of ATP hydrolyzed
rapidly by 2 M UvrA2 in the first turnover. The lag of
∼100 ms preceding the burst indicates that a slow step(s)
occurs before/at ATP hydrolysis as well and is followed by
Pi release. This experiment was repeated at varying con-
centrations of UvrA2 and constant ATP (1 mM) to accu-
rately determine the stoichiometry of ATP hydrolysis from
the burst amplitude of the first turnover (Supplementary
Figure S4B). In addition, complementary experiments were
performed at constant UvrA2 (2 M) and increasing ATP
concentrations to determine how the different nucleotide
binding affinities of proximal (weak) and distal (tight) sites
impact ATPase activity. As shown in Figure 5B, the burst
of Pi release increases with ATP concentration, approach-
ing half-maximum at ∼350 M and maximum at >1.5 mM.
The need for such high ATP concentrations implies that the
low affinity proximal sites play an important role in the AT-
Pase activity of UvrA2. The data from all these experiments
were analyzed by global fitting to a model ATPase mecha-
nism, as shown in Scheme 1 and explained below.
A minimal kinetic model for UvrA2 ATPase activity
The goal was to develop a kinetic mechanism with the mini-
mal number of steps and parameters required to simultane-
ously fit all the ATPase data described above. The measured
nucleotide binding (Figures 2 and 3) and ATPase rates (Fig-
ure 5 and Supplementary Figure S4B) were used as initial
estimates and allowed to float during data fitting, as was the
number of ATPase sites catalyzing the burst of hydrolysis.
The raw data, together with details of model development
and data fitting by KinTek Explorer, are available as Supple-
mentary Data at NAR Online (46,47). The best fit model is
shown in Scheme 1A, and the corresponding rate constants
are shown in Table 2 and Scheme 1B, which also includes
findings from experiments with UvrA2 mutants described
below. The fits are shown as dashed lines overlaid on the
corresponding experimental data in Figure 5A,B and Sup-
plementary Figure S4B. The reaction begins with ATP bind-
ing rapidly to the two high affinity distal sites (step 1; KD1 =
1 M; UvrA2•ATP2D) and two low affinity proximal sites
(step 2; KD2 = 350 M; UvrA2•ATP2D-2P). ATP binding is
followed by a slow step that has been designated as ATP
hydrolysis (step 3; k3 = 2.5 s−1), and then another step des-
ignated as Pi release (step 4; k4 = 20 s−1). The final step in
the reaction, which limits the steady state turnover rate, is
designated as ADP release (step 5; k5a = 0.5 s−1 or k5b = 0.2
s−1 depending on the number of active sites per turnover, as
explained further below).
These are the minimal number of steps required to simul-
taneously fit all the ATPase data described above and obtain
well constrained parameters for each step (error analysis by
FitSpace Explorer is described in Supplementary Data, and
the resulting limits on rate constants are shown in Table 2
and Supplementary Figure S4C) (48). The model mecha-
nism shows that: (i) the burst rate is determined by at least
two steps, which we propose are associated with ATP hy-
drolysis at 2.5 s−1 and subsequent Pi release at 20 s−1 (note
that these two rates likely reflect slow protein conforma-
tional dynamics that enable relatively fast ATP hydrolysis
and Pi release events); (ii) the best fit burst amplitude (n) of
two ATP molecules per UvrA2 (Supplementary Figure S4B)
confirms that only two of the four ATPase sites catalyze fast
ATP hydrolysis and Pi release. Important questions that re-
main unresolved are: which two sites on UvrA2, proximal
or distal, have burst activity, and what is the slow step that
limits steady state turnover. These are addressed in the fol-
lowing sections.
The high ATP concentration required for a maximal
burst either implicates the low affinity proximal sites in
rapid ATP hydrolysis or implies that ATP binding to these
sites is required for rapid ATP hydrolysis by the distal sites.
These two possibilities were investigated by analyzing the
UvrA2 ATPase mutants. The Walker A mutant K37AUvrA2,
in which ATP binding to proximal sites is disrupted while
distal sites are intact, shows no burst and suffers near com-
plete loss of activity (Figure 6A), consistent with an im-
portant role for the proximal sites in rapid ATP hydrolysis
by UvrA2. However, the Walker B mutant E512AUvrA2, in
which proximal ATP binding remains intact but hydrolysis
is disrupted, exhibits a burst of ATP hydrolysis and Pi re-
lease by the wild-type distal sites followed by linear steady
state (kcat = 0.3 s−1; linear slope/2 sites × [E512AUvrA2]),
similar to wild-type UvrA2 (Figure 6A, Table 1). The data
fit to the same mechanism in Scheme 1 yield k3 = 2 s−1, k4 =
42 s−1, k5a = 0.6 s−1 and n = 1.3 Pi/E512AUvrA2, which dif-
fer at most 2-fold from wild-type parameters (Table 2). The
corresponding distal site Walker A mutant K643AUvrA2, in
which distal ATP binding is disrupted while proximal sites
are intact, shows no burst and has very low ATPase activity
(Figure 6B). Moreover, the Walker B mutant E854AUvrA2,
in which distal ATP binding remains intact but hydrol-
ysis is disrupted, exhibits a lag and no burst activity by
the wild-type proximal sites. A faster kcat = 0.6 s−1 (lin-
ear slope/2 sites × [E512AUvrA2]) suggests that the proxi-
mal ATPase is stimulated slightly when distal sites are ATP-
bound (note: the proximal ATPase is inhibited when dis-
tal sites are ADP-bound; Supplementary Figure S5). To-
gether these results confirm that the distal sites are respon-
sible for the initial burst of ATP hydrolysis, and that ATP
binding to the proximal sites is required for this activity.
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Figure 5. Two sites on UvrA2 catalyze a burst of ATP hydrolysis and phosphate (Pi) release. Pre-steady state kinetics of Pi release were measured by mixing
UvrA2 and MDCCPBP reporter with ATP at (A) increasing UvrA2 (final: 0.125–2 M UvrA2, 1 mM ATP and 15 M MDCCPBP; 2 M UvrA2 trace
shown; Supplementary Figure S4) or (B) increasing ATP (final: 2 M UvrA2, 10 M to 2 mM ATP and 15 M MDCCPBP). After a slight lag, Pi is released
rapidly in a burst phase followed by a slow linear phase that yields kcat = 0.2 ± 0.03 s−1 (slope/4 × [UvrA2]; Table 1). Simultaneous fitting of data at all
UvrA2 and ATP concentrations to a minimal ATPase mechanism (Scheme 1) yields k3 = 2.45 ± 0.04 s−1 that limits the burst rate, and a maximum burst
amplitude n = 1.9 ± 0.03 ATP molecules hydrolyzed rapidly per UvrA2 per turnover (Table 2); gray dashed lines show the fit.
Scheme 1. A minimal kinetic model of the UvrA2 ATPase mechanism. (1A) All ATPase kinetic data obtained for wild-type UvrA2 were fit to this model,
with rate and affinity constants measured in mant-nucleotide binding/release and ATP hydrolysis/Pi release experiments serving as initial estimates for
global fitting by KinTek Explorer (Supplementary Data). The best fit rate constants and stoichiometry are listed in Table 2 and shown in bold in (1B),
which also includes ATPase site specific information from mutant analysis. The reaction starts with (1) rapid ATP binding by the high affinity distal sites
(ATP2D), and then (2) the low affinity proximal sites (ATP2D-2P). A subsequent slow step (3) that we speculate is associated with ATP hydrolysis by the
distal sites (ADP2D, Pi2D) is followed by (4) fast Pi release. Finally, a slow step involving (5a) ADP release from distal sites, or additionally (5b) ATP
hydrolysis and product release by proximal sites, limits the catalytic turnover rate (kcat).
Table 2. Best fit parameters for the UvrA2 ATPase mechanism
Parameters Best-fit values Event
ak1 b 3 ± 0.0003 × 104 M−1 s−1c (2.8–3.3) ATP binding (distal sites)
k-1 0.03 s−1 ATP dissociation
KD1 1 M
KD2 350 M ATP binding (proximal sites)
k3 2.45 ± 0.04 s−1 (2.2–2.9) ATP hydrolysis
k4 19 ± 0.6 s−1 (14–24) Pi release
k5a 0.44 ± 0.009 s−1 (0.38–0.52) ADP release (two active sites/turnover)
k5b 0.18 ± 0.002 s−1 (0.16–0.21) ADP release (four active sites/turnover)
n 1.9 ± 0.03 Burst ATPase sites
aParameters in bold were linked during global fitting and confidence contour analysis.
bStandard errors are shown for parameters allowed to float during data fitting.
cUpper and lower limits for parameters from confidence contour analysis are in parentheses.
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Figure 6. ATP binding to the proximal sites permits rapid ATP hydrolysis and Pi release by the distal sites. Pre-steady state Pi release kinetics were measured
for UvrA2 proximal and distal site Walker A and B mutants as described for wild-type in Figure 5 (final: 2 M UvrA2, 2 mM ATP and 15 M MDCCPBP);
wild-type data and fit from Figure 5B are shown for comparison. (A) Proximal site mutants: K37AUvrA2 has no burst and very low activity while E512AUvrA2
shows a burst of Pi release followed by a slow linear phase at kcat = 0.3 s−1 (slope/2 × [E512AUvrA2]); gray dashed line shows the fit to Scheme 1 (k3 = 2
± 0.03 s−1, k4 = 42 ± 3 s−1, k5 = 0.6 ± 0.01 s−1, n = 1.3 ± 0.05 Pi/E512AUvrA2). (B) Distal site mutants: K643AUvrA2 has no burst and very low activity
while E854AUvrA2 shows a lag followed by a fast linear phase at kcat = 0.6 s−1 (slope/2 × [E854AUvrA2]). The double Walker A mutant K37A-K643AUvrA2
has almost no detectable activity (gray trace).
This finding was incorporated into Scheme 1B at step 3
(UvrA2•ATP2P•ADP2D•Pi2D). Scheme 1B also depicts the
possibility that (i) only the two distal sites hydrolyze ATP
per catalytic turnover or (ii) that the two proximal sites also
hydrolyze ATP, except at a slow, turnover-limiting rate af-
ter burst hydrolysis by the distal sites (total four active sites
per turnover). In best fit model, k5a limits the steady state
rate to 0.5 s−1 in case of two active sites, and k5b limits it to
0.2 s−1 in case of four active sites (note that the measured
kcat of 0.2 s−1 for wild-type UvrA2 assumes four active sites
per turnover; Table 1). Finally, the results also demonstrate
that the proximal and distal sites are allosterically linked,
since information about the nucleotide occupancy and AT-
Pase activity of one site is communicated to the other site
and influences its activity.
Differential effects of native and lesion DNA on the proximal
and distal site ATPase mechanisms
A key question driving this study is how UvrA2 integrates
its ATPase and DNA-binding activities to initiate NER. To
address this question, we measured the ATPase kinetics of
UvrA2 bound to two types of DNAs: a 50 bp undamaged
(native) duplex and one with an identical sequence plus a
centrally located fluorescein adduct (a fluorescein lesion is
a good model substrate for bacterial NER) (20,61,62). Our
measurements revealed that UvrA2 binds fluorescein lesion-
containing DNA ∼4-fold tighter than native DNA (KD =
12 nM versus 45 nM; Supplementary Figure S6), which is
in line with earlier reports (24,63–68). Neither type of DNA
appears to affect the nucleotide binding kinetics (Supple-
mentary Figure S7; Table 1). However, both DNAs stimu-
late the steady state ATPase rate (linear phase in Figure 7A,
Table 1) with kcat = 0.8 s−1 and 1.4 s−1 for the native and the
lesion DNA, respectively, compared with 0.2 s−1 for UvrA2
alone, indicating significant changes in the reaction mech-
anism (the same kcat values were obtained from malachite
green-based steady state experiments) (60); note: to avoid
saturation of the MDCCPBP reporter due to this high AT-
Pase rate, pre-steady state measurements were performed at
a lower UvrA2 concentration (0.25 M) than in the absence
of DNA (2 M; Figure 5). In the presence of native DNA,
UvrA2 again shows a short lag, a burst of ATP hydrolysis
and Pi release, and then a linear steady state phase; how-
ever, the burst amplitude is higher than for protein alone
(Figure 7A). The data were fit to the mechanism shown in
Scheme 1, and in this case allowing the number of ATPase
sites to float during fitting yields a burst amplitude of ∼5
ATP hydrolyzed per UvrA2 (k3 = 2.4 s−1, k4 = 30 s−1, k5
= 1 s−1, n = 5.4 ± 0.3 Pi/UvrA2). We interpret this result
to mean that all four sites in the UvrA2–native DNA com-
plex hydrolyze ATP rapidly (versus only the two distal sites
in UvrA2 alone); the overestimate of five sites instead of
four may arise from fitting error given the relatively small
difference between the burst and linear rates. Also, while
the step following Pi release is accelerated by native DNA
(step 5), it remains slow enough to limit turnover. Figure 7A
also shows that in the presence of fluorescein lesion DNA,
UvrA2 ATPase kinetics change again, showing no burst ac-
tivity, just a fast linear phase following a short lag. This re-
sult means that in the UvrA2–lesion complex, the slow step
after ATP hydrolysis and Pi release has been accelerated and
does not limit the turnover rate; instead, a step before or at
ATP hydrolysis has become rate limiting.
Additional information on these rate-limiting step(s) is
needed in order to understand what changes are induced by
DNA in the UvrA2 ATPase mechanism. In many ATPases,
catalytic turnover is associated with and limited by ADP re-
lease, and we hypothesized this might be the case for UvrA2
as well (also note that ADP co-purifies with UvrA2 and
multiple ADP-bound UvrA2 structures have been solved,
indicating high affinity). We expected ADP release rates to
increase by about 4- and 7-fold in the presence of native and
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Figure 7. Native duplex DNA stimulates ATP hydrolysis by all four sites and subsequent ADP release limits turnover; fluorescein lesion DNA stimulates
ADP release such that ATP hydrolysis or Pi release limits turnover. (A) Pre-steady state Pi release kinetics were measured by mixing UvrA2, DNA and
MDCCPBP with ATP (final: 0.25 M UvrA2, +/- 1 M DNA, 1 mM ATP and 15 M MDCCPBP). Without DNA, UvrA2 exhibits a burst of two Pi per
dimer as in Figure 5. With native DNA, UvrA2 exhibits a higher burst amplitude, indicating rapid ATP hydrolysis by all four sites, followed by a linear
phase at kcat = 0.8 s−1 (slope/4 × [UvrA2]). Data at various UvrA2 concentrations in the presence of native DNA fit to Scheme 1 yield k3 = 2.4 ± 0.1 s−1,
k4 = 30 ± 4 s−1, k5 = 1 ± 0.03 s−1, n = 5.4 ± 0.3 Pi/UvrA2; gray dashed line shows the fit. In contrast, lesion DNA stimulates UvrA2 ATPase activity
but there is no burst, only a linear phase at kcat = 1.4 s−1 (slope/4 × [UvrA2]). (B and C) Mant-ADP dissociation was measured by pre-incubating the
nucleotide, UvrA2 and DNA, and mixing with excess unlabeled ADP or ATP chase (final: 0.1 M UvrA2, 0.2 M DNA, 10 M mant-ADP and 2 mM
ADP or ATP). The decrease in fluorescence over time was fit to a single exponential to determine koff. With ADP chase (B), native or lesion DNA has
no significant effect on slow mant-ADP release from UvrA2 at koff = 0.03–0.04 s−1. With ATP chase (C), however, mant-ADP is released >70-fold faster
at koff = 2.3 ± 0.1 s−1, and the rate is further accelerated by ∼4-fold to 9 s−1 and ∼6-fold to 13 s−1 with native and lesion DNA, respectively. These rate
increases correlate with the DNA-induced increases in kcat (A and Table 1).
lesion DNA, respectively, corresponding to the increases
in ATPase turnover rate noted above (kcat = 0.2 s−1, 0.8
s−1 and 1.4 s−1 for UvrA2 alone, and with the native and
lesion DNAs, respectively; Figure 7A, Table 1). However,
as shown in Figure 7B, the rate of mant-ADP dissociation
from distal sites on DNA-bound UvrA2 remains unchanged
at 0.03 s−1, as observed in the absence of DNA (Figure 2C).
Note that in these experiments we used excess unlabeled
ADP as a passive chase to prevent mant-ADP rebinding to
UvrA2 after dissociation. But, since the proximal and dis-
tal sites exhibit asymmetric nucleotide occupancy and al-
losteric communication, we also tested ATP as chase, won-
dering if ATP binding by the proximal sites might affect the
mant-ADP bound at distal sites. Indeed, when excess unla-
beled ATP is added to the UvrA2–mant-ADP complex in
the absence of DNA, we observe ∼70-fold faster release of
mant-ADP at 2 s−1 (Figure 7C). The presence of native and
lesion DNA further stimulates mant-ADP release by 4- and
6-fold to 9 and 13 s−1, respectively (Figure 7C). While the
absolute release rates of the mant-ADP analog are faster
than the ATPase kcat values (Table 1), the match between
the relative increases in both rates induced by DNA strongly
indicates that native and lesion DNA binding to UvrA2 al-
ters the rate of ADP release following ATP hydrolysis and
Pi release.
To summarize the results thus far with wild-type UvrA2:
(i) ATP-bound proximal sites trigger ADP release from dis-
tal sites; (ii) in the absence of DNA, ADP release limits cat-
alytic turnover following ATP hydrolysis by distal sites; (iii)
when UvrA2 binds native DNA, ADP release from distal
sites is accelerated following hydrolysis by all four sites, but
is still slow enough to limit the turnover rate and finally, (iv)
when UvrA2 binds a lesion, further acceleration of ADP re-
lease means an earlier step in the reaction (prior to/at ATP
hydrolysis) becomes rate limiting instead of ADP release.
In order to examine these findings in more detail and de-
termine the effects of DNA on each ATPase site, we also
analyzed the Walker A and B mutants in the presence of
DNA as described below.
Figure 8A shows results from pre-steady state ATPase ex-
periments with wild-type and mutant UvrA2 in the pres-
ence of native DNA. The Walker A mutant K37AUvrA2, in
which proximal ATP binding is disrupted while distal sites
are intact, suffers near complete loss of activity, as seen in
the absence of DNA (Figure 6A). The Walker B mutant
E512AUvrA2, in which proximal ATP binding is preserved
but hydrolysis is disrupted, exhibits a burst of ATP hydrol-
ysis and Pi release by the wild-type distal sites, followed
by the linear steady state (kcat = 0.6 s−1), again as seen in
the absence of DNA (Figure 6A). These results show that
in the UvrA2–native DNA complex, ATP binding to the
weak proximal sites remains necessary for ATP hydrolysis
by the distal sites, and that native DNA does not funda-
mentally alter the distal site ATPase mechanism, except to
speed up the kcat to some extent (likely by accelerating ADP
release; Figure 9). The corresponding distal site mutants,
K643AUvrA2 and E854AUvrA2, in which proximal sites are in-
tact, do not exhibit any burst activity with native DNA, just
as in the absence of DNA but, notably, the Walker A mu-
tant K643AUvrA2, in which distal ATP binding is disrupted,
has a >10-fold faster ATPase rate (1.4 s−1 with DNA ver-
sus 0.1 s−1 without DNA; Figures 8A and 6B, respectively).
This result shows that native DNA stimulates ATP hydroly-
sis and ADP release by the proximal sites on UvrA2 (when
the distal sites are empty).
Next, Figure 8B shows results from experiments in the
presence of fluorescein lesion-containing DNA. Again, the
proximal site Walker A mutant K37AUvrA2 shows near com-
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Figure 8. Native and fluorescein lesion DNAs have different effects on proximal and distal site ATPase mechanisms. Pre-steady state Pi release kinetics
were measured for DNA-bound UvrA2 Walker A and B mutants as described for wild-type in Figure 7 (final: 0.25 M UvrA2, 1 M DNA, 1 mM ATP and
15 M MDCCPBP). (A) With the native duplex, K37AUvrA2 shows no burst and has little activity, while E512AUvrA2 exhibits a burst of ATP hydrolysis and
Pi release followed by a slow linear phase at kcat = 0.6 s−1 (slope/2 × [E512AUvrA2]), as in the absence of DNA (Figure 6A, green trace). K643AUvrA2 and
E854AUvrA2 do not exhibit burst activity, and the linear rates differ than in the absence of DNA at kcat = 1.4 s−1 and 0.3 s−1, respectively. (B) With lesion
DNA, K37AUvrA2 shows no burst and has little activity, while E512AUvrA2 exhibits a slight burst and faster kcat = 2 s−1 (slope/2 × [E512AUvrA2]). Both
K643AUvrA2 and E854AUvrA2 show no burst and have low activity at kcat = 0.3 s−1. The double Walker A mutant K37A-K643AUvrA2 has little detectable
activity (gray trace).
plete loss of activity, affirming that ATP binding to prox-
imal sites is important for ATP hydrolysis by distal sites
in the UvrA2–lesion DNA complex as well. The proximal
site Walker B mutant E512AUvrA2 exhibits a fast ATPase
rate similar to wild-type UvrA2 (kcat = 2 s−1), indicating
that lesion DNA stimulates ADP release from distal sites
and step(s) prior to ATP hydrolysis and Pi release become
rate-limiting for catalytic turnover. In contrast, both distal
site Walker A and B mutants, K643AUvrA2 and E854AUvrA2,
which have intact proximal sites, exhibit low ATPase rates
(kcat = 0.3 s−1), indicating that unlike native DNA, a lesion
suppresses proximal site ATPase activity.
Complementary experiments measuring mant-ADP re-
lease from UvrA2 in the presence of DNA confirm that ATP
binding by proximal sites triggers ADP release from dis-
tal sites, and both native and lesion DNA further acceler-
ate ADP release (Figure 9). Specifically, the data show that
K37AUvrA2 exhibits the slow, basal rate of mant-ADP re-
lease from the intact distal sites under all conditions, since
the mutant proximal sites cannot bind ATP; DNA-bound
E512AUvrA2 exhibits faster mant-ADP release from the in-
tact distal sites, since the mutant proximal sites can bind
ATP; K643AUvrA2 doesn’t show any change in signal, since
the mutant distal sites cannot bind mant-ADP and the in-
tact proximal sites do not bind mant-ADP stably at low con-
centrations; and finally, DNA-bound E854AUvrA2 exhibits
faster mant-ADP release from the mutant distal sites, since
the intact proximal sites can bind ATP. The results from all
the nucleotide binding and ATPase experiments with wild-
type and mutant UvrA2 are summarized and interpreted in
the context of available structural and biochemical data in
the next section.
DISCUSSION
The critical question of how UvrA2 ATPase activity is
mechanochemically coupled to the search for lesions and
initiation of DNA repair has been tackled previously (re-
viewed in (1)). However, UvrA2 presents a complex case
as an ABC-type ATPase with two distinct active sites per
monomer, and the workings of the two pairs of sites on the
dimer are not resolved. The goal of this study was to deter-
mine, for the first time, the transient kinetics of ATP bind-
ing, hydrolysis and product release catalyzed by each site in
three physiological contexts––free of DNA, and bound to
native or lesion-containing DNA. Our results provide new
information about the ATPase mechanism of each site, and
how the sites are influenced by each other and by DNA.
Based on these findings, and information from prior bio-
chemical and structural studies, we propose a model of how
each ATPase site contributes to UvrA2 function in NER
(Figure 10).
UvrA2 ATPase mechanism in the absence of DNA
We determined that the two distal sites on UvrA2 bind nu-
cleotides tightly and hydrolyze ATP rapidly, whereas the
two proximal sites bind nucleotides weakly and hydrolyze
ATP slowly. This striking asymmetry is evident in the high
affinity nucleotide binding and the exclusive burst of ATP
hydrolysis and Pi release by the distal sites in the absence
of DNA; as described earlier, inspection of a high reso-
lution UvrA2 structure offers a molecular explanation for
the differential activities of the two sites. We also found ev-
idence of allosteric communication between the sites, the
most striking being that ATP binding by the proximal sites
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Figure 9. DNA stimulates ADP release from the distal site, only on ATP binding to the proximal site. Mant-ADP dissociation with ATP chase was
measured for UvrA2 proximal and distal site Walker A and B mutants as described for wild-type in Figure 7C (final: 0.1 M UvrA2, 0.2 M DNA, 10
M mant-ADP and 2 mM ATP). (A) K37AUvrA2 exhibits slow mant-ADP release with or without DNA as it cannot bind the ATP needed to stimulate
ADP release from distal sites. (B) K643AUvrA2 exhibits no signal since proximal sites do not bind mant-ADP at the low concentration tested (Figure 3).
(C) E512AUvrA2 and (D) E854AUvrA2 exhibit proximal site ATP and DNA binding-induced stimulation of mant-ADP release from distal sites as observed
with wild-type UvrA2 (Figure 7C).
is necessary for ATP hydrolysis, ADP release and catalytic
turnover by the distal sites (note: the reverse is not true,
but nucleotide occupancy at distal sites does alter proximal
site activity to some extent as well). Interactions across the
dimer linking Walker A and B sub-structures have been pro-
posed previously as a conduit for communication between
proximal and distal sites (26). Figure 10A shows the AT-
Pase mechanism for apo UvrA2, wherein high affinity dis-
tal sites remain ATP-bound until ATP binding to the >300-
fold lower affinity proximal sites (A2) triggers fast hydroly-
sis and Pi release (A3) followed by slower ADP release (A4),
which limits catalytic turnover (this step also requires ATP-
bound proximal sites). Meanwhile proximal sites hydrolyze
ATP at a slower rate and release both products rapidly (A5,
A6). It is unclear if UvrA2 has an obligate sequential AT-
Pase mechanism, i.e. if proximal sites must hydrolyze ATP
after each turnover of the distal sites, or if they hydrolyze
ATP stochastically at a low frequency while the distal sites
continue cycling (two pathways lead back to A2 in Figure
10A). In either case, P2ATP-D2ADP (A3) accumulates in the
reaction during steady state. Note that the low nucleotide
affinity proximal sites may empty often, resulting in tran-
sient Pempty-D2ADP species, but at high ATP concentration
the equilibrium should favor P2ATP-D2ADP.
UvrA2 ATPase activity has been linked to significant
changes in its conformation and dynamics, as detailed
below. UvrA2 structures from different organisms have
been determined in nucleotide-free, P2ADP-D2ADP or Pempty-
D2ADP state, with most in open conformation (including the
T. maritima UvrA2 structure reported here; Supplementary
Figure S3A) with a shallow and wide DNA binding surface
(23–26), and one structure (in complex with UvrB) in closed
conformation with a deep and narrow DNA binding sur-
face (15). Open UvrA2 can accommodate both native and
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Figure 10. A summary of the differential effects of DNA on the UvrA2 ATPase mechanism. (A) Absent DNA, all ATPase sites on UvrA2, distal (D, tight
binding = dark color) and proximal (P, weak binding = light color), binds ATP and only distal sites hydrolyze ATP and release phosphate rapidly. Rate
limiting proximal ATP-induced ADP release from distal sites leads to accumulation of a P2ATP-D2ADP species in steady state (A3). The proximal sites also
hydrolyze ATP, but at a relatively slow rate especially when distal sites are empty, and perhaps not in every turnover. (B) When UvrA2 is bound to native
DNA, both distal and proximal sites hydrolyze ATP and release Pi rapidly, resulting in a distinct, fully ADP-bound species, P2ADP-D2ADP (B3); weak
proximal affinity for ADP can lead to Pempty-D2ADP (B4); ADP release from distal sites remains rate limiting. (C) When UvrA2 is bound to a lesion, distal
sites hydrolyze ATP and release both Pi and ADP rapidly; however, ATP hydrolysis by proximal sites is suppressed, thus these sites remain ATP-bound
in the reaction through P2ATP-D2ATP, P2ATP-D2ADP, P2ATP-Dempty species (C2-C4), with P2ATP-D2ATP (C2) having the longest lifetime. Drawing key is
shown top right; pink numbers highlight UvrA2 species that may affect differential interactions with DNA.
damaged DNA, whereas the closed form appears to pre-
clude binding of DNA distorted by damage (15). One im-
portant feature of ABC ATPase sites is the conserved signa-
ture domain (Figure 1B and C), which changes conforma-
tion in concert with ATP binding, hydrolysis and product
release, coupling these events to changes in protein structure
and interactions (69–72). In UvrA2, the proximal site signa-
ture domain II is notable as it presents cationic residues on
the DNA-binding surface in both open and closed UvrA2
forms, and contributes to the UvrA2–UvrB binding inter-
face as well (15,23). Nucleotide-bound/free UvrA2 struc-
tures reveal signature domain II in different conformations,
suggesting it could affect ATPase-driven changes in UvrA2
interactions with DNA and UvrB. Such dynamism has
not been reported for distal site signature domain I. A C-
terminal zinc-binding hairpin within the proximal site sig-
nature domain II also adopts different conformations and
is implicated in ATPase-modulated interactions of UvrA2
with damaged DNA (the UvrA2 structure reported here
shows the hairpin in a new, intermediate position; Sup-
plementary Figure S3B) (7,42). These movements depend
more on distal site ATPase activity, illustrating an asym-
metric allosteric effect of the distal site reaction on proximal
site structure (42). Prior studies also indicate that UvrA2
dimerizes more effectively in the presence of ATP than non-
hydrolyzable ATPS or ADP (39), and that an ATPase-
active distal site favors dimerization while the proximal site
may be empty (33). UvrA2 also binds more specifically to
lesions in the presence of ATP than ATPS, ADP or no
nucleotide (33,39). All of these results indicate the need for
a mixed ATP/ADP/nucleotide-free UvrA2 species to initi-
ate NER, and provide functional validation for our find-
ing that the protein cycles through rapid ATP hydrolysis by
the distal sites and produces a significant fraction of mixed
P2ATP-D2ADP (or Pempty-D2ADP) dimer in steady state, ready
to interact with DNA and locate a lesion either via 3D or
combined 3D and localized 1D diffusion (5,6).
UvrA2 ATPase mechanism in the presence of native DNA
Interaction between UvrA2 and native DNA has an asym-
metric allosteric effect on the ATPase mechanism, with
proximal sites undergoing significant change and distal sites
less so. The proximal sites still bind nucleotide weakly,
but ATP hydrolysis is accelerated when distal sites can hy-
drolyze ATP or are empty. Meanwhile, the distal sites still
bind nucleotide tightly and require ATP binding by prox-
imal sites for rapid ATP hydrolysis and Pi release. DNA
stimulates ADP release from distal sites resulting in faster
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catalytic turnover, but this step remains rate-limiting. Thus,
DNA-bound UvrA2 has the ATPase mechanism outlined in
Figure 10B, wherein the distal sites remain ATP-bound un-
til proximal ATP binding (B2) triggers fast hydrolysis and Pi
release by all four sites (B3). The weak proximal sites release
ADP (B4), and subsequent ATP binding (B5) enables ADP
release from distal sites (B6). This in turn promotes ATP
hydrolysis by proximal sites (B7) and fast ADP release to
continue the reaction cycle. Notably, due to DNA-induced
changes in the mechanism, UvrA2 transitions more rapidly
through the ATPase reaction and through species less likely
to form in the absence of DNA, such as P2ADP-D2ADP (B3)
and Pempty-D2ADP (B4). Also, since distal ADP release is still
rate-limiting, the P2ATP-D2ADP species (B5) can accumulate
in steady state as in the absence of DNA, except the turnover
rate is faster.
UvrA2 structures determined in open form are in either
nucleotide-free (23,24), fully ADP-bound (25,26) or, in one
case, in Pempty-D2ADP state (15), suggesting that ATP hy-
drolysis by one or both ATPase sites favors this conforma-
tion (the fully ADP-bound structure reported here further
supports this hypothesis; Supplementary Figure S3A). The
closed form of UvrA2 has nucleotides in all four sites, but
their identity is not resolved (15). As noted earlier, the struc-
tures indicate that open UvrA2 can bind both native and
damaged DNA, whereas the closed form cannot accom-
modate DNA distorted by damage. It has been proposed
that UvrA2 cycles repeatedly through open-closed forms to
check the duplex for lesions as it cycles through the AT-
Pase reaction (15). Past studies indicate that UvrA2 binds
native DNA non-specifically in the absence or presence of
ATP, ATPS or ADP, but ATPS favors and ADP im-
pairs the interaction (33,34), and distal site ATPase activity
in particular weakens it (34). Accordingly, we propose that
changes in the ATPase mechanism on binding native DNA,
i.e. ATP binding followed by hydrolysis by all four sites and
accelerated ADP release, allow UvrA2 to transition faster
through ATP (closed)- and ADP (open)-bound forms that
have higher and lower affinity for the duplex, respectively,
thereby enabling lesion search. Furthermore, the Pempty-
D2ADP UvrA2 structure shows outward rotation of signa-
ture II domain away from ATP binding domain I, which
disrupts some critical DNA contacts (15). We speculate that
native DNA-induced stimulation of proximal ATP hydrol-
ysis and ADP release promotes formation of this UvrA2
species, and the resulting transient dissociation from DNA
enables the 3D/localized 1D diffusion search mechanism
proposed recently based on single molecule imaging data
(5).
UvrA2 ATPase mechanism in the presence of damaged DNA
Encounter with a lesion in DNA has a different allosteric
effect on UvrA2, with both sites undergoing significant, dis-
tinct changes in their ATPase mechanism. ATP hydrolysis
is suppressed at the proximal sites, irrespective of nucleotide
occupancy at distal sites. The distal sites still require prox-
imal ATP binding to catalyze ATP hydrolysis and Pi re-
lease, but ADP release is accelerated and no longer limits
the turnover rate. Thus, lesion-bound UvrA2 has the AT-
Pase mechanism outlined in Figure 10C, wherein the dis-
tal sites remain ATP-bound until proximal ATP binding
(C2) triggers fast ATP hydrolysis as well as Pi and ADP
release by distal sites (C3, C4). The proximal sites are sta-
bilized in an ATP-bound state with low catalytic activity
(C4, C5), while distal sites can continue to turnover. More-
over, since steps prior to ATP hydrolysis and product release
by the distal site are now rate limiting, distal nucleotide-
free or ATP-bound states have longer lifetime than ADP-
bound states, which favors UvrA2 species such as P2ATP-
Dempty (C4) and P2ATP-D2ATP (C2), and high ATP concen-
tration favors P2ATP-D2ATP.
After finding a lesion, UvrA2 must orchestrate its hand-
off to UvrB for lesion verification. As noted earlier, out-
ward movement of signature II domain in the Pempty-D2ADP
open UvrA2 form can disrupt interactions with DNA and
UvrB, implying that ATP binding by proximal sites pro-
motes these interactions (15). Consistent with this inter-
pretation, the proximal Walker A mutant has low affinity
for UvrB and is defective in loading UvrB on the lesion,
whereas the distal Walker A mutant is less affected (15,33).
We propose that changes in the UvrA2 ATPase mechanism
on lesion binding, i.e. stabilization of the ATP-bound prox-
imal site and ongoing catalytic turnover by the distal site
allows UvrA2 to remain localized at the lesion and recruit
UvrB (38). Subsequent ATP hydrolysis and ADP release
by the proximal site would reset the signature II domain,
promoting UvrA2 dissociation and UvrB access to the le-
sion. The only crystal structure of UvrA2 bound to DNA
containing a pair of opposing fluorescein lesions is in open
form (23), with all four ATPase sites empty and signature II
domain in a distinct conformation compared with P2ADP-
D2ADP and Pempty-D2ADP structures (15,26). Based on the
ATPase mechanism of lesion-bound UvrA2 described here,
this structure could reflect an early state, before lesion spe-
cific interactions promote ATP-bound proximal sites and
ATP hydrolysis by the distal sites for recruiting UvrB. Al-
ternately, the structure could reflect a late state after ATP
hydrolysis and ADP release, ready to dissociate from DNA
and make room for UvrB at the lesion.
A mechanochemical model of ATPase-driven UvrA2 actions
during NER
The ATPase kinetic mechanism determined in this study of-
fers a view of the mechanochemical coupling in UvrA2 as it
searches for damage lesions in DNA and initiates NER. As
seen in other well-studied ATPases, including ABC trans-
porters (30), each step is closely linked to the next in both
the mechanical and chemical cycles. For UvrA2, we posit
that ATP binding increases affinity for DNA, and DNA
binding in turn promotes UvrA2 closure around a native
duplex, which triggers ATP hydrolysis, followed by open-
ing of ADP-bound/nucleotide-free UvrA2 with weakened
contacts and lower affinity for the duplex, until an ADP–
ATP switch resets the cycle and the protein can continue
scanning DNA. Lesion binding would block UvrA2 closure,
which in turn would alter the ATPase mechanism and main-
tain UvrA2 in proximal ATP-bound form with higher affin-
ity for DNA and UvrB, setting the stage for UvrB entry.
Presumably, a subsequent event would trigger ATP hydrol-
ysis and ADP release, resulting in lesion hand-off to UvrB
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and UvrA2 exit. While many of the transient events in this
model have not been explicitly measured, the UvrA2 AT-
Pase mechanism presented here will facilitate more specific
interpretation of structural and kinetic data on its interac-
tions with DNA and UvrB, and related conformational dy-
namics, to understand how this protein uses ATP to initiate
NER.
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